Aquestive Therapeutics, Inc. (AQST) Shareholders’ equity 2017–2025
Aquestive Therapeutics, Inc. (AQST) shareholders’ equity at each fiscal year-end, per SEC filings.
-$33.7MFY2025 · since FY2017: -$26.5M → -$33.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.7M | +44.0% |
| FY2024 | -$60.2M | +43.5% |
| FY2023 | -$106.5M | +10.2% |
| FY2022 | -$118.6M | -44.3% |
| FY2021 | -$82.1M | -69.4% |
| FY2020 | -$48.5M | -692.2% |
| FY2019 | -$6.1M | -160.7% |
| FY2018 | $10.1M | +138.0% |
| FY2017 | -$26.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice